“We are pleased to announce our partnership with Jeeva Informatics,” said Sara Tylosky, CEO Farmacon Global. “Working with Harsha K. Rajasimha Founder and CEO Jeeva Informatics, our clients will experience faster patient recruitment and better patient retention in studies, particularly in rare disease trials.”
Harsha Rajasimha, Founder and CEO of Jeeva Informatics Solutions, an eClinical cloud platform, said “The Jeeva eClinical Cloud™ was developed by researchers with empathy who listen and learn to help clinical researchers, hospital sites, academic medical centers, CROs, and biopharmaceutical sponsors accelerate patient enrollment by 3x faster. We listened to a couple of thousand stakeholders of clinical research. Delays in patient recruitment and retention, ensuring diversity, equity, and inclusion, generating quality clinical evidence of safety and efficacy of treatments, tracking patient’s adherence to medication, and compliance with regulatory agencies such as Institutional Review Boards, FDA, EMA, GDPR, and other guidelines are critical factors. Jeeva Informatics solves these challenges.”
https://www.youtube.com/watch?v=7J6uTy09P6s
Farmacon Global and JEEVA Informatics’ eclinical cloud platform announce partnership.
Tylosky, noted, “Clinical research involves generation of high quality reliable clinical evidence of patient safety and outcomes. The traditional model of generating evidence during patients’ in-person visits to brick-and-mortar sites can no longer be relied solely on. Researchers and patients are questioning traditional models and seeking increased flexibility in the post-pandemic world. This is why we have partnered with Jeeva Informatics with our specialization in Latin America. We will accelerate Patient Recruitment and Retention, bringing time and cost performance benefits in clinical trials to our clients, especially in the realm of Rare Disease research and trials.
“As one of our specialties is Rare Patient Disease recruitment across Latin America, we were pleased to meet at the Rare Patient Global Genes Conference this past September. For an assessment of how we can assist you now in all phases and demands of a clinical trial, please contact me.”
Tylosky will be happy to provide this presentation with the necessary customization for your organization. Contact info: Sara Tylosky, CEO Farmacon Global
